Status:
COMPLETED
Magnesium as Adjuvant for Sciatic Block
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Hallux Valgus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to evaluate if Magnesium added to ropivacaine can reduce onset time and can enhance offset time.
Detailed Description
Patients are randomly divided into two groups: group "M" (Ropivacaina 7,5 mg/ml with Mg 4 mg/Kg)and group"C" (without Mg). Standard monitoring is applied to each patient in perioperative period. An i...
Eligibility Criteria
Inclusion
- given consent
- allux valgus correction surgery
Exclusion
- allergy to local anesthetic
- infection in the site of puncture
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02198547
Start Date
March 1 2014
End Date
September 1 2022
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Campus Bio-Medico
Rome, Italy, 00128